Page last updated: 2024-08-24

gemcitabine and Hematologic Malignancies

gemcitabine has been researched along with Hematologic Malignancies in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jones, RB; Li, D; Nieto, Y; Shinozuka, K; Tang, H	1
Becker, PS; Cassaday, RD; De Padova, N; Lindstrom, S; Puri, A; Ulrickson, ML	1
Dumontet, C	1
Chow, KU; Hoelzer, D; Kim, SZ; Kriener, S; Mitrou, PS; Schui, DK; Sterry, W; Weidmann, E; Zollner, TM	1
Daugherty, CK; Huo, D; Janisch, L; Larson, RA; Odenike, OM; Ratain, MJ; Sobecks, RM; Zimmerman, TM	1
Brunson, CY; Green, MR; Kneuper-Hall, R; Lal, A; Rocha Lima, CM; Urbanic, JJ	1
Johnson, SA	1
Boehrer, S; Bojunga, J; Chow, KU; Fauth, F; Hoelzer, D; Martin, H; Mitrou, PS; Rummel, MJ; Schneider, B; Stieler, M; Weidmann, E	1

Reviews

4 review(s) available for gemcitabine and Hematologic Malignancies

Article	Year
[The role of gemcitabine in hematology]. Bulletin du cancer, 2002, Volume: 89 Spec No Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Deoxycytidine; DNA Damage; DNA, Neoplasm; Drug Design; Gemcitabine; Hematologic Neoplasms; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Multiple Myeloma; Neoplasm Proteins; Nucleotides; Ribonucleotide Reductases; Salvage Therapy; Treatment Outcome	2002
CD4+ CD56+ neoplasia: clinical and biological features with emphasis on cytotoxic drug-induced apoptosis and expression of sialyl Lewis X. Leukemia & lymphoma, 2003, Volume: 44, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; CD4 Antigens; CD56 Antigen; Cladribine; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Hematologic Neoplasms; Humans; Immunophenotyping; Lewis X Antigen; Oligosaccharides; Sialyl Lewis X Antigen	2003
Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies. Seminars in oncology, 2001, Volume: 28, Issue:3 Suppl 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Gemcitabine; Hematologic Neoplasms; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Pancreatic Neoplasms	2001
Nucleoside analogues in the treatment of haematological malignancies. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:6 Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Biological Transport; Cladribine; Clinical Trials as Topic; Cytarabine; Cytosine; Deoxycytidine; Dioxolanes; Economics, Pharmaceutical; Gemcitabine; Guidelines as Topic; Hematologic Neoplasms; Humans; Molecular Structure; Nucleosides; Pentostatin; Vidarabine	2001

Trials

1 trial(s) available for gemcitabine and Hematologic Malignancies

Article	Year
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Fatigue; Feasibility Studies; Female; Gemcitabine; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Thrombocytopenia	2004

Article

Year

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:6

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Fatigue; Feasibility Studies; Female; Gemcitabine; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Thrombocytopenia

2004

Other Studies

3 other study(ies) available for gemcitabine and Hematologic Malignancies

Article	Year
Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:5 Topics: Adult; Aged; Deoxycytidine; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Female; Gemcitabine; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Prospective Studies	2016
Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm. American journal of hematology, 2017, Volume: 92, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dendritic Cells; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Hematologic Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Taxoids	2017
Induction of apoptosis by cladribine (2-CdA), gemcitabine and other chemotherapeutic drugs on CD34+/CD38+ and CD34+/CD38- hematopoietic progenitor cells: selective effects of doxorubicin and 2-CdA with protection of immature cells. Leukemia & lymphoma, 2002, Volume: 43, Issue:2 Topics: Antigens, CD34; Antineoplastic Agents; Apoptosis; Cladribine; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Gemcitabine; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Mitoxantrone	2002